Global Umbilical Cord Blood Banking Market, Trends and Report 2025

The global market for umbilical cord blood banking has projected a CAGR of 11.4% from 2017 to 2025. Initially, the market was projected at USD 3124 in 2016. However, the recent growth in the umbilical cord blood banking market is expected to rise to USD 8178 by 2025.

The first successful umbilical cord blood transplantation took place in 1988. Since then, around 40,000 transplantations have been done globally. Research reveals that umbilical cord blood stem cells have been beneficial in treating many diseases that were believed to be incurable. These include cerebral palsy, autism, and even brain injury. 

Umbilical cord blood treatment has shown positive results in treating lymphoma, leukemia, sarcoma, sickle cell anemia, metabolic disorders and some genetic diseases. 

The first cord blood bank was established in New York in 1992. Today, there are several private and public cord blood banks across the world. The private cord blood bank accounted for 65% of the market share in 2016. This segment is estimated to grow further at a CAGR of 12.5% between 2017 and 2025. Some of the reasons driving the growth of the private cord blood bank sector are:

• Complete ownership of the stored umbilical cord blood lies with the donor

• Flexibility in terms of umbilical cord blood collection

• Secured and assured access to the stored umbilical cord blood

• Easy access to the cord blood in times of need

• Rising public awareness about the benefits of umbilical cord blood banking

• Growing of facilities for umbilical cord blood harvesting and storage

• Increased use of umbilical cord blood stem cells in treating diseases; more than 80 diseases can be cured using umbilical cord blood

• Umbilical cord blood can be used for both transplants and regenerative medicine

• Rising prevalence of cancer and increased adoption of umbilical cord blood stem cells-based treatment

• Supportive government policies, encouraging umbilical cord blood stem cell-based treatments

Increasing demand for umbilical cord blood for stem cell research has fueled the need to have more umbilical cord blood banks around the world. However, umbilical cord blood procured from public cord blood banks is used for research mostly. In developing countries, there is a rising demand to set up more cord blood banks to facilitate stem cell research.

Some of the key players in the umbilical cord blood banking sector are:

• CBR Systems Inc

• ViaCord Inc

• China Cord Blood Corporation

• Cordlife Group Ltd

• Lifecell

• StemCyte Inc

• Cord Blood America Inc

• Cryo-Cell International Inc

• Cryo-Save AG

• Vita 34 AG

The umbilical cord blood banking market has grown exponentially in recent years. Technological advancements and increased awareness will further fuel the growth of the market.